Roche's Genentech launches DTC program amid Trump's MFN directive
Source: SeekingAlpha
2025-10-16 12:18:38 ET
More on Roche Holding
- Roche's Giredestrant: A Ray Of Hope On A Cloudy Horizon?
- Roche Holding AG (RHHBY) Discusses On Pharma Day 2025 (Transcript)
- Roche Holding AG (RHHBY) Special Call - Slideshow
- Roche, Eli Lilly Alzheimer's blood diagnostic test wins FDA approval
- Roche's Genentech gets FDA nod for lung cancer treatment
Read the full article on Seeking Alpha
For further details see:
Roche’s Genentech launches DTC program amid Trump’s MFN directive
Roche Holding Ltd ADR
NASDAQ: RHHBY
RHHBY Trading
-2.05% G/L:
$53.15 Last:
712,829 Volume:
$52.87 Open:
RHHBY Latest News
March 09, 2026 02:10:00 am
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
RHHBY Stock Data
$361,973,933,704
6,306,832,002
N/A
43
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
